Inventor · disambiguated record
Min Li
Also filed as: LI MIN · LI MIN-JENG
46 granted patents·41 pending applications·130 citations·filing 1996–2025
97Inventor score
Files withCOLGATE PALMOLIVE CO14UNIV HONG KONG BAPTIST4UNIV HONG KONG BAPTIST UNIV4LI MIN3ACADEMIA SINICA2
Top patents by PatentIndex Score
87 records- 0191US11530195B1Protacs targeting coronavirus 3CL protease and preparation method and application thereofSHAANXI PANLONG PHARMACEUTICAL CO LTD·Filed 2022·Granted Dec 20, 2022·5 cites·5 claims
- 0289US11518759B1Protacs based on VHL ligand targeting coronavirus 3CL protease and preparation method and application thereofSHAANXI PANLONG PHARMACEUTICAL CO LTD·Filed 2022·Granted Dec 6, 2022·2 cites·4 claims
- 0389US11331253B2Personal care compositions for treating odor causing bacteria and methods for the sameCOLGATE PALMOLIVE CO·Filed 2019·Granted May 17, 2022·1 cites·18 claims
- 0486US8916517B2Analogs of pituitary adenylate cyclase-activating polypeptide (PACAP) and methods for their useCOY DAVID HOWARD·Filed 2010·Granted Dec 23, 2014·11 cites·12 claims
- 0586US2024164999A1Personal Care CompositionsCOLGATE PALMOLIVE CO·Filed 2024·Application pending·0 cites
- 0685US10208290B2Virion display array for profiling functions and interactions of human membrane proteinsUNIV JOHNS HOPKINS·Filed 2014·Granted Feb 19, 2019·5 cites·25 claims
- 0783US5856155ACompounds and related methods for modulating potassium ion channels and assays for such compoundsUNIV JOHNS HOPKINS MED·Filed 1996·Granted Jan 5, 1999·41 cites·6 claims
- 0882US8557763B2Synthetic peptides that enhance tight junction permeabilityTAMIZ AMIR·Filed 2012·Granted Oct 15, 2013·3 cites·6 claims
- 0982US8460667B2EPHA2 receptor antagonist antibodiesBLANC VERONIQUE·Filed 2007·Granted Jun 11, 2013·8 cites·65 claims
- 1080US9434760B2Prolinamide derivatives as thrombin inhibitors, preparation method and application thereofLI MIN·Filed 2011·Granted Sep 6, 2016·4 cites·2 claims
- 1179US12194124B2Personal care compositions for treating odor causing bacteria and methods for the sameCOLGATE PALMOLIVE CO·Filed 2022·Granted Jan 14, 2025·0 cites·13 claims
- 1279US2025107993A1Personal Care CompositionsCOLGATE PALMOLIVE CO·Filed 2024·Application pending·0 cites
- 1378US9353048B2Compound as KCNQ potassium channel agonist, preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA·Filed 2012·Granted May 31, 2016·6 cites·4 claims
- 1477USRE47123EEPHA2 receptor antagonist antibodiesSANOFI SA·Filed 2007·Granted Nov 13, 2018·2 cites·72 claims
- 1575US12201713B2Personal care compositionsCOLGATE PALMOLIVE CO·Filed 2022·Granted Jan 21, 2025·0 cites·17 claims
- 1675US2025195382A1Personal Care CompositionsCOLGATE PALMOLIVE CO·Filed 2024·Application pending·0 cites
- 1773US2024197594A1Personal care compositionsCOLGATE PALMOLIVE CO·Filed 2023·Application pending·0 cites
- 1873US2021275419A1Personal Care CompositionsCOLGATE PALMOLIVE CO·Filed 2021·Application pending·0 cites
- 1973US2021275418A1Personal Care CompositionsCOLGATE PALMOLIVE CO·Filed 2021·Application pending·0 cites
- 2072US12226512B2Personal care compositionsCOLGATE PALMOLIVE CO·Filed 2020·Granted Feb 18, 2025·0 cites·17 claims
- 2171US9375457B2Composition comprising Rhizoma coptidis, Cortex phellodendri and Fructus gardeniae and for treating neurodegenerative diseasesUNIV HONG KONG BAPTIST·Filed 2014·Granted Jun 28, 2016·1 cites·10 claims
- 2271US8992912B2Methods of use for antibodies that specifically bind to the EphA2 receptorSANOFI SA·Filed 2013·Granted Mar 31, 2015·1 cites·29 claims
- 2370US5958374AMethod for preparing radionuclide-labeled chelating agent-ligand complexesUNIV CALIFORNIA·Filed 1996·Granted Sep 28, 1999·37 cites·14 claims
- 2469US9006181B2Treatment of renal dysfunction and multiple myeloma using PACAP compoundsARIMURA AKIRA·Filed 2005·Granted Apr 14, 2015·2 cites·32 claims
- 2569US2025179118A1Novel dipeptide compounds and uses thereofSHANGHAI SYNERGY PHARMACEUTICAL SCIENCES LTD·Filed 2024·Application pending·0 cites
- 2667US12091552B2Reactive dyes and preparation methods thereofUNIV NANTONG·Filed 2023·Granted Sep 17, 2024·0 cites·7 claims
- 2766US2019153135A1Activator Compositions, Their Preparation, And Their Use In CatalystsGRACE W R & CO·Filed 2019·Application pending·0 cites
- 2864US2024382610A1Nectin-4 antibodies and conjugatesTALLAC THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2963US2025143999A1Personal Care CompositionsCOLGATE PALMOLIVE CO·Filed 2025·Application pending·0 cites
- 3062US2024010701A1Combination therapies for treating urothelial carcinomaALX ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 3161US2024065947A1Personal care compositionsCOLGATE PALMOLIVE CO·Filed 2023·Application pending·0 cites
- 3261US2024374746A1Sirp-alpha antibodies and conjugatesTALLAC THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3360US12171850B2Personal care compositionsCOLGATE PALMOLIVE CO·Filed 2020·Granted Dec 24, 2024·0 cites·7 claims
- 3460US10221264B2Activator compositions, their preparation, and their use in catalystsGRACE W R & CO·Filed 2013·Granted Mar 5, 2019·0 cites·11 claims
- 3560US2007196860A1Methods for Measuring Real Time Kinase ActivityINVITROGEN CORP·Filed 2007·Application pending·0 cites
- 3660US2025304549A1Hydroxyamide derivative and use thereofSICHUAN HUIYU PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 3759US12018018B2Pregabalin lactam methylene dimer and preparation method thereforZHEJIANG HUAHAI PHARM CO LTD·Filed 2018·Granted Jun 25, 2024·0 cites·15 claims
- 3859US2025121082A1Anti-cd228 antibody and drug conjugate thereofSHANDONG BOAN BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 3959US2024065954A1Personal Care CompositionsCOLGATE PALMOLIVE CO·Filed 2023·Application pending·0 cites
- 4058US10683518B2Mutated nucleotide molecule, and transformed plant cells and plants comprising the sameACADEMIA SINICA·Filed 2017·Granted Jun 16, 2020·0 cites·11 claims
- 4158US10174033B2N6-substituted adenosine derivatives and N6-substituted adenine derivatives and uses thereofSHI JIANGONG·Filed 2009·Granted Jan 8, 2019·1 cites·6 claims
- 4257US2025059159A1Plpro inhibitorsSHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 4356US11712693B2Integrated selective capture, sequestration, fluidic isolation, electrical lysis and analysis of single cellsUNIV IOWA STATE RES FOUND INC·Filed 2019·Granted Aug 1, 2023·0 cites·19 claims
- 4456US2011268789A1Use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with anticancer agentsLI MIN·Filed 2009·Application pending·0 cites
- 4556US2025110137A1Composition for Detecting Occult Blood in Excreta, and Preparation Method Therefor and Use ThereofSHANGHAI PEIGE HOSPITAL MAN CO LTD·Filed 2023·Application pending·0 cites
- 4655US2014171377A1Novel peptides that enhance tight junction permeabilityALBA THERAPEUTICS CORP·Filed 2013·Application pending·0 cites
- 4755US2024285658A1Pharmaceutical assembly comprising tobramycin inhalation solution and use thereofJOINCARE PHARMACEUTICAL GROUP IND CO LTD·Filed 2022·Application pending·0 cites
- 4854US2023134345A1Chimeric antigen receptor comprising third signal receptor and use thereofSHANGHAI LONGYAO BIOTECHNOLOGY INC LTD·Filed 2022·Application pending·0 cites
- 4952US9604987B2Synthesis of autophagy inducing compound and the uses thereofUNIV HONG KONG BAPTIST UNIV·Filed 2015·Granted Mar 28, 2017·0 cites·9 claims
- 5051US11167000B2Uses and development of neurodefend for treating neurodegenerative diseasesUNIV HONG KONG BAPTIST UNIV·Filed 2018·Granted Nov 9, 2021·0 cites·16 claims
Showing the top 50 of 87 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Min Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →